0001741198-20-000001.txt : 20201013 0001741198-20-000001.hdr.sgml : 20201013 20201013092612 ACCESSION NUMBER: 0001741198-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201013 DATE AS OF CHANGE: 20201013 EFFECTIVENESS DATE: 20201013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Emergo Therapeutics, Inc. CENTRAL INDEX KEY: 0001741198 IRS NUMBER: 814088686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-377621 FILM NUMBER: 201234943 BUSINESS ADDRESS: STREET 1: 6208 FAYETTEVILLE ROAD #104 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-599-4381 MAIL ADDRESS: STREET 1: 6208 FAYETTEVILLE ROAD #104 CITY: DURHAM STATE: NC ZIP: 27713 D 1 primary_doc.xml X0708 D LIVE 0001741198 Emergo Therapeutics, Inc. 6208 FAYETTEVILLE ROAD #104 DURHAM NC NORTH CAROLINA 27713 919-599-4381 DELAWARE None None Corporation true 2016 Moise Khayrallah 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Executive Officer Director John E. Bailey, Jr. 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Director Robert Helmedag 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Director Margaret Powell 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Director Pharmaceuticals Decline to Disclose 06b false 2020-10-09 false true false 0 5024352 3524137 1500215 false 77 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false Emergo Therapeutics, Inc. Moise Khayrallah Moise Khayrallah CEO 2020-10-12